Literature DB >> 3827882

A triple-binding-domain model explains the specificity of the interaction of a sphingolipid activator protein (SAP-1) with sulphatide, GM1-ganglioside and globotriaosylceramide.

C H Wynn.   

Abstract

The conformations of the neutral glycosphingolipid, globotriaosylceramide, and of the methyl ester of GM1-ganglioside have been predicted by energy-minimization techniques and compared with those previously obtained for GM1- and GM2-ganglioside. A triple-binding-domain model is put forward to explain known specificities of binding between these glycosphingolipids and activator proteins. This model suggests that hydrophobic interactions, electrostatic interactions and hydrogen-bonding between sugar residues are important. The model is discussed in relation to previous studies on the effect of chemical modification of glycosphingolipids on their ligand properties.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3827882      PMCID: PMC1147509          DOI: 10.1042/bj2400921

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

1.  [A cerebrosidesulfatase from swine kidney].

Authors:  E Mehl; H Jatzkewitz
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1964

2.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.

Authors:  E Conzelmann; K Sandhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide.

Authors:  S C Li; H Kihara; S Serizawa; Y T Li; A L Fluharty; J S Mayes; L J Shapiro
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

4.  Molecular cloning of the sphingolipid activator protein-1 (SAP-1), the sulfatide sulfatase activator.

Authors:  N Dewji; D Wenger; S Fujibayashi; M Donoviel; F Esch; F Hill; J S O'Brien
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

5.  Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1).

Authors:  K Inui; D A Wenger
Journal:  Arch Biochem Biophys       Date:  1984-09       Impact factor: 4.013

6.  Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2.

Authors:  S C Li; S Serizawa; Y T Li; K Nakamura; S Handa
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

7.  Purification and properties of galactosylceramide sulfatase activator from human liver.

Authors:  T Mitsuyama; S Gasa; T Nojima; N Taniguchi; A Makita
Journal:  J Biochem       Date:  1985-09       Impact factor: 3.387

8.  Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophy.

Authors:  K Inui; M Emmett; D A Wenger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  Calculation of the conformation of glycosphingolipids. 1. Beta-D-glucosyl-N-(2-D-hydroxyoctadecanoyl)-D-dihydrosphingosine (glucosyl-ceramide) and alpha-D-N-acetylneuraminyl-(2----3)-beta-D-galactose.

Authors:  C H Wynn; A Marsden; B Robson
Journal:  J Theor Biol       Date:  1986-03-07       Impact factor: 2.691

10.  Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.

Authors:  E Conzelmann; J Burg; G Stephan; K Sandhoff
Journal:  Eur J Biochem       Date:  1982-04-01
  10 in total
  1 in total

1.  Crystal structure of saposin B reveals a dimeric shell for lipid binding.

Authors:  Victoria E Ahn; Kym F Faull; Julian P Whitelegge; Arvan L Fluharty; Gilbert G Privé
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.